These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 28232583)

  • 1. Identification of an HLA class I allele closely involved in the autoantigen presentation in acquired aplastic anemia.
    Zaimoku Y; Takamatsu H; Hosomichi K; Ozawa T; Nakagawa N; Imi T; Maruyama H; Katagiri T; Kishi H; Tajima A; Muraguchi A; Kashiwase K; Nakao S
    Blood; 2017 May; 129(21):2908-2916. PubMed ID: 28232583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequent loss of HLA alleles associated with copy number-neutral 6pLOH in acquired aplastic anemia.
    Katagiri T; Sato-Otsubo A; Kashiwase K; Morishima S; Sato Y; Mori Y; Kato M; Sanada M; Morishima Y; Hosokawa K; Sasaki Y; Ohtake S; Ogawa S; Nakao S;
    Blood; 2011 Dec; 118(25):6601-9. PubMed ID: 21963603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hematopoiesis by iPSC-derived hematopoietic stem cells of aplastic anemia that escape cytotoxic T-cell attack.
    Espinoza JL; Elbadry MI; Chonabayashi K; Yoshida Y; Katagiri T; Harada K; Nakagawa N; Zaimoku Y; Imi T; Takamatsu H; Ozawa T; Maruyama H; Hassanein HA; Khalifa A Noreldin A; Takenaka K; Akashi K; Hamana H; Kishi H; Akatsuka Y; Nakao S
    Blood Adv; 2018 Feb; 2(4):390-400. PubMed ID: 29472446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained clonal hematopoiesis by HLA-lacking hematopoietic stem cells without driver mutations in aplastic anemia.
    Imi T; Katagiri T; Hosomichi K; Zaimoku Y; Hoang Nguyen V; Nakagawa N; Tajima A; Yoshizato T; Ogawa S; Nakao S
    Blood Adv; 2018 May; 2(9):1000-1012. PubMed ID: 29720492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of HLA-B*40:02-restricted T cells possessing cytotoxic and suppressive functions against haematopoietic progenitor cells from a patient with severe aplastic anaemia.
    Inaguma Y; Akatsuka Y; Hosokawa K; Maruyama H; Okamoto A; Katagiri T; Shiraishi K; Murayama Y; Tsuzuki-Iba S; Mizutani Y; Nishii C; Yamamoto N; Demachi-Okamura A; Kuzushima K; Ogawa S; Emi N; Nakao S
    Br J Haematol; 2016 Jan; 172(1):131-4. PubMed ID: 25929998
    [No Abstract]   [Full Text] [Related]  

  • 6. [A loss-of-function mutation in exon1 of limited HLA class I alleles is common in patients with aplastic anemia].
    Mizumaki H
    Rinsho Ketsueki; 2021; 62(4):270-277. PubMed ID: 33967152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hematopoietic stem progenitor cells lacking HLA differ from those lacking GPI-anchored proteins in the hierarchical stage and sensitivity to immune attack in patients with acquired aplastic anemia.
    Yoroidaka T; Hosokawa K; Imi T; Mizumaki H; Katagiri T; Ishiyama K; Yamazaki H; Azuma F; Nanya Y; Ogawa S; Nakao S
    Leukemia; 2021 Nov; 35(11):3257-3267. PubMed ID: 33824463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance of KIR Ligand-Missing Leukocytes to NK Cells In Vivo in Patients with Acquired Aplastic Anemia.
    Nguyen MAT; Hosokawa K; Yoroidaka T; Maruyama H; Espinoza JL; Elbadry MI; Mohiuddin M; Tanabe M; Katagiri T; Nakagawa N; Chonabayashi K; Yoshida Y; Arima N; Kashiwase K; Saji H; Ogawa S; Nakao S
    Immunohorizons; 2020 Jul; 4(7):430-441. PubMed ID: 32680908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA associations, somatic loss of HLA expression, and clinical outcomes in immune aplastic anemia.
    Zaimoku Y; Patel BA; Adams SD; Shalhoub R; Groarke EM; Lee AAC; Kajigaya S; Feng X; Rios OJ; Eager H; Alemu L; Quinones Raffo D; Wu CO; Flegel WA; Young NS
    Blood; 2021 Dec; 138(26):2799-2809. PubMed ID: 34724566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A frequent nonsense mutation in exon 1 across certain HLA-A and -B alleles in leukocytes of patients with acquired aplastic anemia.
    Mizumaki H; Hosomichi K; Hosokawa K; Yoroidaka T; Imi T; Zaimoku Y; Katagiri T; Anh Thi Nguyen M; Cao Tran D; Ibrahim Yousef Elbadry M; Chonabayashi K; Yoshida Y; Takamatsu H; Ozawa T; Azuma F; Kishi H; Fujii Y; Ogawa S; Tajima A; Nakao S
    Haematologica; 2021 Jun; 106(6):1581-1590. PubMed ID: 32439725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paroxysmal nocturnal hemoglobinuria with copy number-neutral 6pLOH in GPI (+) but not in GPI (-) granulocytes.
    Ueda Y; Nishimura J; Murakami Y; Kajigaya S; Kinoshita T; Kanakura Y; Young NS
    Eur J Haematol; 2014; 92(5):450-3. PubMed ID: 24931618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA Class I Allele Loss and Bone Marrow Transplantation Outcomes in Immune Aplastic Anemia.
    Zaimoku Y; Katagiri T; Nakagawa N; Imi T; Maruyama H; Takamatsu H; Ishiyama K; Yamazaki H; Miyamoto T; Nakao S
    Transplant Cell Ther; 2024 Mar; 30(3):281.e1-281.e13. PubMed ID: 37972732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of 6pLOH in an aplastic anemia patient by in phase HLA genotyping.
    Kikkawa E; Shiina T; Shigenari A; Ozaki Y; Suzuki S; Ando K; Onizuka M
    HLA; 2020 May; 95(5):465-469. PubMed ID: 31970935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance and origin of leukocytes that lack HLA-A allele expression in patients with acquired aplastic anemia.
    Maruyama H; Katagiri T; Kashiwase K; Shiina T; Sato-Otsubo A; Zaimoku Y; Maruyama K; Hosokawa K; Ishiyama K; Yamazaki H; Inoko H; Ogawa S; Nakao S
    Exp Hematol; 2016 Oct; 44(10):931-939.e3. PubMed ID: 27250585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immune pathophysiology of bone marrow failure].
    Hosokawa K
    Rinsho Ketsueki; 2023; 64(9):908-915. PubMed ID: 37793865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequent HLA-DR loss on hematopoietic stem progenitor cells in patients with cyclosporine-dependent aplastic anemia carrying HLA-DR15.
    Tsuji N; Hosokawa K; Urushihara R; Tanabe M; Zaimoku Y; Katagiri T; Ozawa T; Takamatsu H; Ishiyama K; Yamazaki H; Kishi H; Ogawa S; Nakao S
    Leukemia; 2022 Jun; 36(6):1666-1675. PubMed ID: 35474098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Acquired aplastic anemia].
    Hosokawa K; Nakao S
    Rinsho Ketsueki; 2019; 60(5):417-422. PubMed ID: 31168007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The frequency of HLA class I and II alleles in Pakistani patients with aplastic anemia.
    Rehman S; Saba N; Khalilullah ; Munir S; Ahmed P; Mehmood T
    Immunol Invest; 2009; 38(8):812-9. PubMed ID: 19860590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenicity and impact of HLA class I alleles in aplastic anemia patients of different ethnicities.
    Olson TS; Frost BF; Duke JL; Dribus M; Xie HM; Prudowsky ZD; Furutani E; Gudera J; Shah YB; Ferriola D; Dinou A; Pagkrati I; Kim S; Xu Y; He M; Zheng S; Nijim S; Lin P; Xu C; Nakano TA; Oved JH; Carreno BM; Bolon YT; Gadalla SM; Marsh SG; Paczesny S; Lee SJ; Monos DS; Shimamura A; Bertuch AA; Gragert L; Spellman SR; Babushok DV
    JCI Insight; 2022 Nov; 7(22):. PubMed ID: 36219480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoantibodies frequently detected in patients with aplastic anemia.
    Hirano N; Butler MO; Von Bergwelt-Baildon MS; Maecker B; Schultze JL; O'Connor KC; Schur PH; Kojima S; Guinan EC; Nadler LM
    Blood; 2003 Dec; 102(13):4567-75. PubMed ID: 12947009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.